Gapping down
Solar names lower following disappointing TSL guidance: TSL-2.9% (lowers Q1 shipment guidance; estimates its solar module shipments to be in the range of 540 MW to 570 MW, including 20 MW to 30 MW for its downstream projects), JKS -2.6%, CSIQ -4.4%, CSUN -2.8%.
Select European financial related names showing weakness: NBG -14% (planning EUR 2.1 billion capital raise, according to reports), ING -2.2%, BCS -1.4%, BBVA -0.8%.
Other news: CVM -12.6% (announces proposed public offering of common stock and six month warrants), NQ -9.4% (Muddy Waters Research tweets that NQ Mobile Q4 was 'dismal'), MDT -5.4% ( Federal Court orders preliminary injunction on U.S. Sales of Medtronic's infringing Transcatheter Valve; downgraded to Neutral from Overweight at JP Morgan ), ALU -4.5% (still checking), ERIC-4% (announces change in Executive leadership team), ABBV -3.1% (presents late-breaking results from TURQUOISE-II study in chronic HepatitisC patients with cirrhosis ), BBRY -1.9% (still checking), ASML -1.8% (still checking), YY -1.6% (still checking), AA -1.5% (downgraded at Fitch ), CCL -1.4% (still checking), NOK -1.3% (still checking), ABB -1.2% (still checking), YNDX -1.1% (Russia names were under pressure), BP -0.9% (still checking), MSFT -0.8% (fined $731 mln by EU over browser miscue. according to reports ; downgraded to Hold from Buy at Deutsche Bank ), NUS -0.6% (following late move lower on HLF concerns), JNJ -0.4% (plans to end plans for anti-wrinkle treatment that was to challenge Allergan's Botox, according to reports out Friday prior to close; downgraded to Hold from Buy at Jefferies), GSK -0.3% (may face criminal investigation in Poland, according to reports ).
Analyst comments: STM -2.5% (downgraded to Sell from Neutral at UBS), GLW -0.9% ( downgraded to Hold from Buy at Stifel).
Select European financial related names showing weakness: NBG -14% (planning EUR 2.1 billion capital raise, according to reports), ING -2.2%, BCS -1.4%, BBVA -0.8%.
Other news: CVM -12.6% (announces proposed public offering of common stock and six month warrants), NQ -9.4% (Muddy Waters Research tweets that NQ Mobile Q4 was 'dismal'), MDT -5.4% ( Federal Court orders preliminary injunction on U.S. Sales of Medtronic's infringing Transcatheter Valve; downgraded to Neutral from Overweight at JP Morgan ), ALU -4.5% (still checking), ERIC-4% (announces change in Executive leadership team), ABBV -3.1% (presents late-breaking results from TURQUOISE-II study in chronic HepatitisC patients with cirrhosis ), BBRY -1.9% (still checking), ASML -1.8% (still checking), YY -1.6% (still checking), AA -1.5% (downgraded at Fitch ), CCL -1.4% (still checking), NOK -1.3% (still checking), ABB -1.2% (still checking), YNDX -1.1% (Russia names were under pressure), BP -0.9% (still checking), MSFT -0.8% (fined $731 mln by EU over browser miscue. according to reports ; downgraded to Hold from Buy at Deutsche Bank ), NUS -0.6% (following late move lower on HLF concerns), JNJ -0.4% (plans to end plans for anti-wrinkle treatment that was to challenge Allergan's Botox, according to reports out Friday prior to close; downgraded to Hold from Buy at Jefferies), GSK -0.3% (may face criminal investigation in Poland, according to reports ).
Analyst comments: STM -2.5% (downgraded to Sell from Neutral at UBS), GLW -0.9% ( downgraded to Hold from Buy at Stifel).